These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37395117)

  • 1. G protein activation via chemokine (C-X-C motif) receptor 4 and α
    Gao X; Majetschak M
    FEBS Lett; 2023 Aug; 597(15):2017-2027. PubMed ID: 37395117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α
    Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α
    Gao X; Enten GA; McGee MY; Weche M; Majetschak M
    Pharmacol Res; 2023 Apr; 190():106730. PubMed ID: 36925091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3 regulate vascular α₁-adrenergic receptor function.
    Bach HH; Wong YM; Tripathi A; Nevins AM; Gamelli RL; Volkman BF; Byron KL; Majetschak M
    Mol Med; 2014 Oct; 20(1):435-47. PubMed ID: 25032954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical ligand-induced cross-regulation of chemokine (C-X-C motif) receptor 4 by α
    Gao X; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    Sci Rep; 2018 Feb; 8(1):2730. PubMed ID: 29426850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of heteromeric complexes between chemokine (C-X-C motif) receptor 4 and α
    Gao X; Enten GA; DeSantis AJ; Volkman BF; Gaponenko V; Majetschak M
    Biochem Biophys Res Commun; 2020 Jul; 528(2):368-375. PubMed ID: 32085899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into Mechanisms and Functions of Chemokine (C-X-C Motif) Receptor 4 Heteromerization in Vascular Smooth Muscle.
    Evans AE; Tripathi A; LaPorte HM; Brueggemann LI; Singh AK; Albee LJ; Byron KL; Tarasova NI; Volkman BF; Cho TY; Gaponenko V; Majetschak M
    Int J Mol Sci; 2016 Jun; 17(5):. PubMed ID: 27331810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
    Schafer CT; Chen Q; Tesmer JJG; Handel TM
    Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
    Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
    PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer: An Examination of the Potential of ACKR3 to Modify the Response of CXCR4 to CXCL12.
    Del Molino Del Barrio I; Wilkins GC; Meeson A; Ali S; Kirby JA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30441765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
    Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
    J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteromerization of chemokine (C-X-C motif) receptor 4 with α1A/B-adrenergic receptors controls α1-adrenergic receptor function.
    Tripathi A; Vana PG; Chavan TS; Brueggemann LI; Byron KL; Tarasova NI; Volkman BF; Gaponenko V; Majetschak M
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1659-68. PubMed ID: 25775528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
    Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
    J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACKR3 agonism induces heterodimerization with chemokine receptor CXCR4 and attenuates platelet function.
    Dicenta-Baunach V; Laspa Z; Schaale D; Sigle M; Bayrak A; Castor T; Pillaiyar T; Laufer S; Gawaz MP; Rohlfing AK
    Eur J Clin Invest; 2025 Jan; 55(1):e14327. PubMed ID: 39373210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteromerization between α
    Gao X; DeSantis AJ; Enten GA; Weche M; Marcet JE; Majetschak M
    FEBS Lett; 2022 Oct; 596(20):2706-2716. PubMed ID: 35920096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of the chemokine receptor ACKR3/CXCR7 on CXCL12-mediated effects in cancers with a focus on virus-related cancers.
    Freitas C; Desnoyer A; Meuris F; Bachelerie F; Balabanian K; Machelon V
    Cytokine Growth Factor Rev; 2014 Jun; 25(3):307-16. PubMed ID: 24853339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Context-Dependent Signaling of CXC Chemokine Receptor 4 and Atypical Chemokine Receptor 3.
    Heuninck J; Perpiñá Viciano C; Işbilir A; Caspar B; Capoferri D; Briddon SJ; Durroux T; Hill SJ; Lohse MJ; Milligan G; Pin JP; Hoffmann C
    Mol Pharmacol; 2019 Dec; 96(6):778-793. PubMed ID: 31092552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
    Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
    Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.